In Vitro Activities of Dalbavancin and 12 Other Agents against 329 Aerobic and Anaerobic Gram-Positive Isolates Recovered from Diabetic Foot Infections | Zendy

Ellie J. C. Goldstein | Zendy; Diane M. Citron | Zendy; Yumi A. Warren | Zendy; Kerin L. Tyrrell | Zendy; C. Vreni Merriam | Zendy; Helen T. Fernandez | Zendy

Open Access

In Vitro Activities of Dalbavancin and 12 Other Agents against 329 Aerobic and Anaerobic Gram-Positive Isolates Recovered from Diabetic Foot Infections

Author(s) -

Ellie J. C. Goldstein,

Diane M. Citron,

Yumi A. Warren,

Kerin L. Tyrrell,

C. Vreni Merriam,

Helen T. Fernandez

Publication year - 2006

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00286-06

Subject(s) - dalbavancin , anaerobic exercise , microbiology and biotechnology , gram , in vitro , diabetic foot , foot (prosody) , medicine , gram positive bacteria , anaerobic bacteria , biology , chemistry , diabetes mellitus , antimicrobial , staphylococcus aureus , bacteria , biochemistry , vancomycin , endocrinology , genetics , physiology , linguistics , philosophy

Tests of dalbavancin's in vitro activity against 209 aerobic and 120 anaerobic isolates from pretreatment diabetic foot infections showed an MIC(90) of < or =0.125 microg/ml against methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA), and 120 anaerobes (Clostridium perfringens, other clostridia, Peptoniphilus asaccharolyticus, Finegoldia magna, and Anaerococcus prevotii), compared to respective MIC(90)s for MSSA and MRSA of 0.5 and 1 microg/ml for vancomycin, 4 and 4 microg/ml for linezolid, 0.5 and 0.5 microg/ml for daptomycin, and 0.25 and >8 microg/ml for clindamycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research